Maria Rodriguez, M.D., M.P.H., discusses the positive impact of pharmacist prescribed birth control.

In an NPR story picked up by dozens of outlets across the country, Shoukhrat Mitalipov, Ph.D., expresses concern regarding a Russian scientist’s claim that he intends to create gene-edited babies.

Erick Turner, M.D., expresses skepticism about the newly approved antidepressant esketamine.

Nicole Cirino, M.D., comments on the recent FDA approval of Vyleesi (Bremelanotide) to treat hypoactive sexual desire disorder. According to Cirino, Vyleesi won’t be a first-line treatment for low sexual desire among women, but could add to other treatments like psychotherapy.

17-year-old former Doernbecher patient hands out teddy bears to children receiving care on Doernbecher’s pediatric oncology unit.

The Portland Business Journal profiles Charles Blanke, M.D., including his specialization in treating terminally ill patients and his advocacy for Oregon’s Death with Dignity Act.

Ron Lai says several months of construction time was saved by using a new steel frame system for the 60,000-square-foot OHSU Elks Children’s Eye Clinic.

A team of researchers from OHSU and Oregon State University, led by Arup Indra, Ph.D., identify compounds that “starve” melanoma cells of energy.

OHSU is treating a woman who fell 16 stories down a garbage chute at a Portland building.

OHSU is named as a hospital working to remove barriers to help patients with opioid addiction in an opinion piece about how hospitals can better address the opioid crisis.